HC Wainwright & Co. Maintains Buy on Curis, Raises Price Target to $43

Benzinga · 2d ago
HC Wainwright & Co. analyst Sara Nik maintains Curis (NASDAQ:CRIS) with a Buy and raises the price target from $17 to $43.